Osteonecrosis and Fosamax

since 2001, more than 2,400 people have been diagnosed with osteonecrosis of the jaw () after taking fosamax

Recent studies demonstrate a clear link between osteonecrosis and . The irony is that these drugs, such as , that are prescribed to prevent bone loss may actually be causing bone decay – such as ().

Beasley Allen shareholder Chad Cook, who practices in the firm’s Mass Torts section, is on the Plaintiff’s Discovery Committee for In re Products Liability Litigation, MDL-1789 which is venued in the Southern District of New York Federal Court before the Honorable John F. Keenan, and involves cases of . Chad is also assists with serving on the Science and Administrative Committees for this litigation.

linked to thigh fractures

The FDA reviewed data from an ongoing safety review of oral to determine if use of the drug was related to an increased risk of thigh fractures, specifically low-energy femoral shaft and subtrochanteric fractures.

In October of 2010 the FDA required all manufacturers of to include in the warning section of their label a description of low-energy femoral shaft and subtrochanteric fractures that are associated with the use of drugs in this class.

Chad Cook also has been chosen to help direct litigation related to femur fractures caused by the osteoporosis medication ®. Chad is one of 11 lawyers selected to oversee the consolidated litigation as part of the Plaintiffs Steering Committee (PSC). The litigation, which involves hundreds of cases against Merck Sharp & Dohme, Corp., which manufactures ®, is consolidated under U.S. District Judge Garrett E. Brown, Jr., in the District of New Jersey.

do you need a fosamax lawyer?

If you or a loved one have suffered serious side effects while taking , if you have been diagnosed with osteonecrosis, or if you are experiencing the symptoms asscociated with , or experience thigh fractures while taking , you may have a claim against the manufacturer of .

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.


Latest News

FDA warns of unusual thigh fracture from use of osteoporosis drugs

fosamax70 100x100Widely used osteoporosis drugs designed to prevent bones from breaking may increase the risk of a rare type of thigh fracture, according to the Food and Drug Administration (FDA). The agency notified consumers and health care workers that all  will now carry a new warning about the fractures on their safety labels.

Read the rest of this entry »

FDA review shows no link between bone treatment and thigh fractures

tabletsThe Food and Drug Administration (FDA) says data from an ongoing safety review of oral , such as Fosamax, prescribed for the treatment of bone loss, do not appear to be related to an increased risk of thigh fractures. However, the agency is telling health care professionals to be aware of a possible risk of atypical subtrochanteric femur fractures in patients using .

The ongoing safety review was initiated in June 2008, following published case reports of this specific type of thigh fracture in patients with osteoporosis taking . The agency says it will continue to study this issue along with a team of outside experts, which includes members of the American Society of Bone and Mineral Research Subtrochanteric Femoral Fracture Task Force.

Read the rest of this entry »

Beasley Allen attorney files lawsuit against maker of Fosamax

tabletsThree lawsuits against the makers of Fosamax, a popular medication to prevent bone loss, are slated to go to trial, including one filed in Alabama state court by Beasley Allen attorney W. Chad Cook. The lawsuits are among the nearly 900 cases brought against Merck & Co. by 1,280 plaintiff groups who allege caused them serious jaw problems.

Read the rest of this entry »